VCs in USD 156m round for Quell Therapeutics

  • by

Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company have led a USD 156m Series B funding round for biotechnology business Quell Therapeutics.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *